Luotonin A compound and preparation method and application thereof

A compound and reaction technology, applied in the field of Luotonin A series compounds and their preparation, can solve the problems of no clinical application value, low binding ability, low anti-tumor activity, etc., and achieve easy synthesis and preparation, stable structure, and strong anti-proliferation activity Effect

Active Publication Date: 2020-07-28
HUBEI UNIV OF CHINESE MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to provide a Luotonin A series compound and its Preparation method and application, the Luotonin A series compound described in the present invention has the advantages of stable structure and easy chemical synthesis preparation, and has the effect of inhibiting topoisomerase I activity and anti-tumor proliferation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Luotonin A compound and preparation method and application thereof
  • Luotonin A compound and preparation method and application thereof
  • Luotonin A compound and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0058] Concrete preparation process comprises: compound shown in formula (1) and 2-methylquinoline-3-formic acid ethyl ester in I 2 / TsOH / DMSO system was heated and stirred at 110°C. After the reaction was completed, water was added to precipitate a solid, and the solid was hydrolyzed in alkaline water to obtain the compound represented by formula (2). Under the catalysis of DMF, the compound represented by formula (2) was converted into an acid chloride intermediate with oxalyl chloride, tetrahydrofuran was added after the reaction solvent was removed under reduced pressure, and sodium borohydride was added for reduction to obtain the compound represented by formula (3). The compound represented by formula (3) is subjected to Mitsunobu reaction with triphenylphosphine / diisopropyl azodicarboxylate in dichloromethane to obtain the compound represented by formula (4). The compound shown in formula (4) reacts with amine raw materials in N-methylpyrrolidone by heating to obtain th...

Embodiment 1

[0075] (1) Preparation of 2-(6,7-difluoro-4-oxo-3,4-dihydroquinazolin-2-yl)quinoline-3-carboxylic acid

[0076]

[0077] 2-Amino-4,5-difluorobenzamide (1.72g, 10mmol), ethyl 2-methylquinoline-3-carboxylate (2.28g, 12mmol), iodine (254mg, 1mmol) and p-toluenesulfonate Acid (1.72g, 10mmol) was dissolved in 20mL of DMSO and reacted at 110°C for 3h. After the reaction was completed, it was dropped into a saturated aqueous solution of sodium sulfite while hot, and a large amount of solid was precipitated. After filtering, the filter cake was dissolved in 50mL of methanol, and 4g of hydrogen was added. Sodium oxide solid, react at 50°C for 15min, after the reaction, distill methanol off under reduced pressure, add water and ethyl acetate, separate the layers, wash the water layer twice with ethyl acetate, pour it into a beaker, and use 10% Adjust the pH to 3-4 with hydrochloric acid, a large amount of solids precipitated, filtered, and dried to obtain 2.5 g of a light yellow sol...

Embodiment 2

[0091] Prepare the compound shown in formula (LX2) according to the method similar to Example 1 8-(1,4-Homopiperazin-1-yl)- 9-fluoroquinolino[2',3':3,4]pyrrolo[2,1-b]quinazolin-11(13H)-one , the yield is 40%,

[0092]

[0093] Its NMR carbon spectrum data are:

[0094] 1 H NMR (CDCl 3 ,600MHz)δ=8.35(d,J=37.6Hz,2H),7.97–7.69(m,3H),7.61(s,1H),7.41–7.19(m,1H),5.22(s,2H),3.68 (s,4H),3.14(s,2H), 2.96(s,2H),2.01(s,2H). 13 C NMR (CDCl 3 ,150MHz)δ=159.59,152.49(d,J=247.9Hz),152.42,151.46,149.38,147.68,144.82(d,J=9.0Hz),131.41, 130.64,130.55,129.60,128.72,128.391,127 (d, J=4.4Hz), 112.67 (d, J=25.4Hz), 111.63 (d, J=9.0Hz), 54.80, 51.14, 49.48, 48.26, 47.20, 30.78.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicinal chemistry, and discloses a Luotonin A compound and a preparation method and application thereof. The Luotonin A compound represented by formula (I) and a pharmaceutically acceptable salt thereof are disclosed. R1 is H or halogen, R2 is an ethylenediamine group, a C1-C6 alkyl substituted ethylenediamine group, a piperazinyl group, a C1-C6 alkyl substituted piperazinyl group, a morpholinyl group, a C1-C6 alkyl substituted morpholinyl group, a homopiperazinyl group or a C1-C6 alkyl substituted homopiperazinyl group, and X is C or N. The Luotonin A compound provided by the invention is stable in structure and easy to synthesize and prepare, can be used as a novel topoisomerase I inhibitor, and has relatively strong anti-proliferative activity on cell strains of liver cancer, lung cancer, breast cancer and cervical cancer.

Description

technical field [0001] The present invention relates to the technical field of medicinal chemistry, in particular to a Luotonin A series compound and its preparation method and application Background technique [0002] Topoisomerase regulates important life processes of cells: transcription, translation, mitosis, and nucleic acid repair, etc., which widely exist in prokaryotes and eukaryotes. Humans encode six topoisomerases, which are divided into topoisomerase I (Topo I) and topoisomerase II (Topo II) according to their functions. Due to the frequent proliferation of tumor cells, Topo I is very active, while Topo I in normal cells is not active, making Topo I one of the important targets of antitumor drugs. [0003] Camptothecin, extracted from the bark of Camptothecin, is the most representative topoisomerase I inhibitor. Today, most of its derivatives are clinically used, such as topotecan and irinotecan, for the treatment of colon cancer, ovarian cancer and small cell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D471/14C07D487/04A61P35/00A61K31/519A61K31/551
CPCA61P35/00C07D471/14C07D487/04
Inventor罗来春尤朋涛胡春玲向远航
OwnerHUBEI UNIV OF CHINESE MEDICINE